» Articles » PMID: 9628934

Biologically-generated Primer for PCR: PCR Primer of Unknown Sequence

Overview
Specialty Biochemistry
Date 1998 Jun 17
PMID 9628934
Authors
Affiliations
Soon will be listed here.
Abstract

We describe a method for producing specific PCR primers directly from PCR product, bypassing the usual need to know the primer sequence. Lack of abundance of primers derived from a PCR product is compensated for by the incorporation of an arbitrary 5'TAG sequence which acts as a surrogate template target for the bulk amplification phase. We use the technique to amplify clonospecific rearranged immunoglobulin genes, which have applications as markers of lymphoid neoplasms for tracing the success of therapy. The principle may have wider application wherever conserved and variable regions of DNA are juxtaposed.

References
1.
Deane M, Norton J . Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol. 1990; 20(10):2209-17. DOI: 10.1002/eji.1830201009. View

2.
Deane M, Norton J . Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol. 1991; 77(3):274-81. DOI: 10.1111/j.1365-2141.1991.tb08570.x. View

3.
Jeffreys A, MacLeod A, Tamaki K, Neil D, Monckton D . Minisatellite repeat coding as a digital approach to DNA typing. Nature. 1991; 354(6350):204-9. DOI: 10.1038/354204a0. View

4.
Campana D, Pui C . Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 1995; 85(6):1416-34. View

5.
Brisco M, Condon J, Hughes E, Neoh S, Sykes P, Seshadri R . Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet. 1994; 343(8891):196-200. DOI: 10.1016/s0140-6736(94)90988-1. View